Results

Total Results: 456 records

Showing results for "drugs".

21. References (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
    August 12, 2012 - Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs … Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs … Cardiovascular monitoring and stimulant drugs for attention- deficit/hyperactivity disorder.

22. Section 2, Technical Specifications (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-2-tech-specs.pdf
    February 09, 2018 - defined as a mean heart rate > 2 SD above normal for age in the absence of external stimulus, chronic drugs … as a mean heart rate <10th percentile for age in the absence of external vagal stimulus, β- blocker drugs

23. Section 1, Tables 1-4 (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-1-tables-1-4.pdf
    June 15, 2018 - defined as a mean heart rate > 2 SD above normal for age in the absence of external stimulus, chronic drugs … as a mean heart rate <10th percentile for age in the absence of external vagal stimulus, β-blocker drugs

24. Data Infographics | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/data/infographics/index.html
    March 01, 2024 - Treatment In-Hospital Mortality Rates Related to Diabetes Hospitalizations for Diabetes Drugs … Group Gender and Emergency Department Visits Reduced Median Annual Spending for Retail Drugs

25. Technical Specifications for Timely Fluid Bolus for Children With Severe Sepsis or Septic Shock (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-technical-specifications.pdf
    April 26, 2018 - defined as a mean heart rate > 2 SD above normal for age in the absence of external stimulus, chronic drugs … as a mean heart rate <10th percentile for age in the absence of external vagal stimulus, β-blocker drugs

26. Timely Antiobiotics for Children With Severe Sepesis or Septic Shock Technical Specifications (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-sepsis-antibiotics-technical-specs.pdf
    August 01, 2014 - defined as a mean heart rate > 2 SD above normal for age in the absence of external stimulus, chronic drugs … as a mean heart rate <10th percentile for age in the absence of external vagal stimulus, β-blocker drugs

27. Section 2, Technical Specifications (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-tech-specs.pdf
    June 15, 2018 - defined as a mean heart rate > 2 SD above normal for age in the absence of external stimulus, chronic drugs … as a mean heart rate <10th percentile for age in the absence of external vagal stimulus, β-blocker drugs

28. AHRQ Research Inspires Efforts at Banner Desert To Reduce Drug Errors in E.D. Patients | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/news/newsroom/case-studies/201509.html
    January 01, 2018 - The technicians interview these patients to learn what drugs, vitamins, and supplements they take, as … "Many times, we see patients taking multiple drugs for the same condition, which may or may not be

29. Adolescents who present to the ED with psychotic symptoms should receive the laboratory tests | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/pqmp/measures/adolescents-psychotic-symptoms.html
    August 01, 2021 - Psychosis PQMP COE:  COE4CCN Associated NQF # and Name:  2806, Adolescent Psychosis: Screening for Drugs

30. Surge in Drug Shortages Occurred in Wake of Pandemic, Study Finds | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/news/newsletters/e-newsletter/908.html
    April 01, 2024 - in JAMA Network Open , researchers analyzed data from 2017 to 2021 and found that 13.7 percent of drugs … Researchers said that injectable drugs, generics and essential World Health Organization medicines had

31. Table 5. Evidence Supporting Emergency Department Pain Assessment for Children With Sickle Cell Disease (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-section-5-table-5.pdf
    April 01, 2014 - Pharmacological pain management consists of the use of nonsteroidal anti‐inflammatory drugs (NSAIDs … Pediatr Drugs 2003; 5(4):229‐241.

32. TeamSTEPPS Fundamentals Course: Module 5. Situation Monitoring | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/teamstepps/instructor/fundamentals/module5/slsitmonitor.html
    July 01, 2018 - A  =  A lcohol and Drugs. F  =  F atigue. E  =  E ating and Elimination. … Matthews, the Team Leader, is calling out orders for drugs, X-rays, and labs.

33. Medicare Version of the Health Plan Survey | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/cahps/surveys-guidance/hp/about/Medicares-CAHPS-HP-Survey.html
    December 01, 2023 - Getting Needed Prescription Drugs. Care Coordination.

34. Data Visualizations | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/data/data-visualization/index.html?page=2
    September 01, 2023 - Hospitalizations Influenza Injuries Mental Disorders Mental Health Nursing Homes Opioids Poverty Prescription Drugs

35. Opioids AHRQ Works: Building Bridges Between Research and Practice (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/topics/impact-opioid-final.pdf
    November 01, 2018 - recovery services  Better data  Better research  Better targeting of overdose-reversing drugs … statistics from 32 HCUP participating States on hospital stays that involve alcohol, opioids, and other drugs

36. Assessing the Availability of the Preconception Component of High-Risk Obstetrical Services by Estimating the Use of Teratogenic Medications Before and During Pregnancy (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-fullreport.pdf
    August 07, 2018 - Assuring that women on high-risk drugs are off of those drugs before they get pregnant is a critical … The scope of actions includes the field of medicinal drugs and specifically outlines goals of: • … Thus, this measure strives to decrease the number of pregnancies exposed to teratogenic drugs. … Pregnancy and lactation labeling (Drugs) final rule. December 2014. … Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008.

37. Medication Discrepancies and Potential Adverse Drug Events During Transfer of Care from Hospital to Home | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/patient-safety/reports/liability/neumiller.html
    August 01, 2017 - Drugs resulting in serious potential ADEs included exemestane, enoxaparin, warfarin, and sublingual nitroglycerin … Minor potential ADEs most often involved OTC agents, antacids, cholesterol lowering drugs, allergic rhinitis … agents, nonsteroidal anti-inflammatory drugs (NSAIDs), and thyroid supplements. … common medication classes involved were antibiotics, antidepressants, antipsychotics, cardiovascular drugs

38. Large-Scale Program To Reduce Heart Disease Risk Could Have Meaningful Health Benefits | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/news/newsletters/e-newsletter/857.html
    March 01, 2023 - Although there was concern that dexamethasone may reduce the effectiveness of the anti-clotting drugs … The authors suggested that study of this interaction is important as use of both drugs may be necessary

39. Library of PCOR Resources | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/pcor/library-of-resources/index.html
    April 01, 2021 - Other records describe observational studies and programs providing access to investigational drugs … Canadian Agency for Drugs and Technologies in Health (CADTH) (Canada) Centre for Reviews and Dissemination

40. Diagnosis & Treatment | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/patients-consumers/diagnosis-treatment/index.html
    May 01, 2018 - information on diseases, conditions, and wellness issues Recalls: Medicine Product safety alerts on food, drugs